A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC.
Clinical trial NCT04606303 · UNKNOWN
Trial details
- NCT number
- NCT04606303
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-18
- Primary completion
- 2023-05-21
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.